US overdose deaths fell in 2023, still topped 100k
New CDC data shows drug overdose deaths dropped for the first time in five years
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
What happened
U.S. overdose deaths declined in 2023 for the first time in five years, according to preliminary data released Wednesday by the Centers for Disease Control and Prevention (CDC). But last year's 107,543 fatal overdoses, while a 3% drop, marked the third straight year of more than 100,000 deaths.
Who said what
The "progress over the last 12 months should make us want to reinvigorate our efforts" to reduce drug-related deaths, said CDC chief medical officer Deb Houry. The "leveling of the overdose curve" is welcome but the death toll remained "historically high" and not enough people are being treated for their addictions, said Dr. Brian Hurley at the American Society of Addiction Medicine.
The report "did not offer reasons for the drop," led by a 3.7% dip in deaths from fentanyl and other synthetic opioids, The New York Times said. "But naloxone, a drug that reverses opioid overdoses, has become more widely available," as have test strips to detect fentanyl.
What next?
The final 2023 overdose numbers will be released in several months, after more state data comes in.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Film reviews: ‘Send Help’ and ‘Private Life’Feature An office doormat is stranded alone with her awful boss and a frazzled therapist turns amateur murder investigator
-
Movies to watch in Februarythe week recommends Time travelers, multiverse hoppers and an Iraqi parable highlight this month’s offerings during the depths of winter
-
ICE’s facial scanning is the tip of the surveillance icebergIN THE SPOTLIGHT Federal troops are increasingly turning to high-tech tracking tools that push the boundaries of personal privacy
-
A fentanyl vaccine may be on the horizonUnder the radar Taking a serious jab at the opioid epidemic
-
Vaccine critic quietly named CDC’s No. 2 officialSpeed Read Dr. Ralph Abraham joins another prominent vaccine critic, HHS Secretary Robert F. Kennedy Jr.
-
Nitazene is quietly increasing opioid deathsThe explainer The drug is usually consumed accidentally
-
Can TrumpRx really lower drug prices?Today’s Big Question Pfizer’s deal with Trump sent drugmaker stocks higher
-
The UK’s opioid crisis: why the stats don’t add upThe Explainer A new report has revealed that the UK’s total of opioid-related deaths could be much greater than official figures show
-
Why the FDA wants to restrict kratom-related productsIn the Spotlight The compound is currently sold across the United States
-
US overdose deaths plunged 27% last yearspeed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive orderspeed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
